Serum Alpha-Feto Protein Screening for Neural Tube Defects: Some Notes for Programme Evaluators

' Brock D.J.H. , Sutcliffer. G. , AFP in the antenatal diagnosis ot anencephaly and spina bifida. Lancet, 1972; ii; 197-199.

2 Brock D.J.H. , Boui Ton A.E. , and Monahan J.M. , Prenatal diagnosis of anencephaly through maternal serum AFP measurement . Lancet , 1973; ii; 923-924.

3 Report of the UK Collaborative Study on AFPs in relation to NTDs. Maternal serum AFP measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Lancet, 1977; i; 1323-1332.

4 Richards I.D.G. , Roberts C.J. and Lloyds. Area differences in the prevalence of neural tube formations in South Wales. A study of possible demographic determinants . Brit.J. Prev. Soc. Med. 1972 ; 26; 89-93.

5 Macv J. Perinatal Mortality - An Area Survey In:— Proceedings of the Eighth Study Group of the Royal College of Obstetricians and Gynaecologists . 1980; 133-147.

6 Clarke M. and Clayton D.G. Quality of obstetric care provided for Asian immigrants in Leicestershire . B. M. J., 1983; i; 621-623.

7 Office of Populations Censuses and Surveys. Congenital Malformations. (1983)Series MB3 No. 5. HMSO.

8 Clarke M. and Claytond.G. The design and interpretation of case-control studies or perinatal mortality . Am. J. Epid., 1981 ;1 113(6); 636-645.

9 Hagard S. , Carilr F. and Milni R.G. Screening for spina bifida cystica. A cost benefit analysis. Brit. J. Prev. Soc. Med., 1976; 30; 40-53.

10 Second Report of the UK Collaborative Study on alpha feto-protein in relation to neural tube defects. Fluid alpha feto-protein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy . Lancet, 1979; ii; 651-661.

11 Clarke M. Feasibility of serum alpha feto-protein screening for fetal neural tube defects . Lancet, 1977; i; 1089.

12 Bennet M.J. , Gau G.S. and Gau D.W. Women's attitudes to screening for neural tube defects. Brit. J. Obs. Gynae . 1980; 87; 370-371.